5,6-Dimethylbenzimidazole

5,6-Dimethylbenzimidazole
Names
Preferred IUPAC name
5,6-Dimethyl-1H-1,3-benzimidazole
Identifiers
3D model (JSmol)
116595
ChEBI
ChEMBL
ChemSpider
DrugBank
ECHA InfoCard 100.008.627
EC Number
  • 209-488-1
279255
KEGG
UNII
  • InChI=1S/C9H10N2/c1-6-3-8-9(4-7(6)2)11-5-10-8/h3-5H,1-2H3,(H,10,11)
    Key: LJUQGASMPRMWIW-UHFFFAOYSA-N
  • InChI=1/C9H10N2/c1-6-3-8-9(4-7(6)2)11-5-10-8/h3-5H,1-2H3,(H,10,11)
    Key: LJUQGASMPRMWIW-UHFFFAOYAV
  • CC1=CC2=C(C=C1C)N=CN2
Properties
C9H10N2
Molar mass 146.193 g·mol−1
Hazards
GHS labelling:
GHS07: Exclamation mark
Warning
H302, H315, H319, H335, H412
P261, P264, P270, P271, P273, P280, P301+P312, P302+P352, P304+P340, P305+P351+P338, P312, P321, P330, P332+P313, P337+P313, P362, P403+P233, P405, P501
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references

5,6-Dimethylbenzimidazole (DMB) is a naturally occurring derivative of benzimidazole with two methyl groups as substituents on the benzene ring.

5,6-Dimethylbenzimidazole is biosynthesized from flavin mononucleotide by the enzyme 5,6-dimethylbenzimidazole synthase.[1]

Occurrence and uses

Biological significance

5,6-Dimethylbenzimidazole is a substructure of true vitamin B12, where it serves as one of the ligands for the cobalt atom. In part of one of the pathways for cobalamin biosynthesis, DMB is a substrate for nicotinate-nucleotide—dimethylbenzimidazole phosphoribosyltransferase. One form of pseudovitamin B12, i.e. a compound usable by B12-dependent lactic acid bacteria but not by humans, has this group replaced with adenyl.[2] Despite production of pseudo B12 in groups as distantly related as lactic acid bacteria and Cyanobacteria, DMB is preferred over adenine by the vast majority of versions of CobT, the enzyme responsible for making the active phosphoribosylated "lower group" of cobalamin.[3]

Medicinal chemistry

Researchers have explored the pharmacological properties of benzimidazole derivatives, with some displaying antimicrobial, antiviral, anticancer, and antifungal activities.[4] The specific medicinal properties of 5,6-dimethylbenzimidazole may vary based on its structural features and substituents.[5]

References

  1. ↑ "5,6-Dimethylbenzimidazole biosynthesis". MetaCyc.
  2. ↑ Santos, Filipe; Vera, José L.; Lamosa, Pedro; de Valdez, Graciela F.; de Vos, Willem M.; Santos, Helena; Sesma, Fernando; Hugenholtz, Jeroen (16 October 2007). "Pseudovitamin is the corrinoid produced by Lactobacillus reuteri CRL1098 under anaerobic conditions". FEBS Letters. 581 (25): 4865–4870. doi:10.1016/j.febslet.2007.09.012. hdl:11336/58580. PMID 17888910.
  3. ↑ Hazra, Amrita B.; Tran, Jennifer L.A.; Crofts, Terence S.; Taga, Michiko E. (October 2013). "Analysis of Substrate Specificity in CobT Homologs Reveals Widespread Preference for DMB, the Lower Axial Ligand of Vitamin B12". Chemistry & Biology. 20 (10): 1275–1285. doi:10.1016/j.chembiol.2013.08.007. PMID 24055005.
  4. ↑ Kumar, Rajnish; Singh, Chanchal; Mazumder, Avijit; Salahuddin; Abdullah, Md. Mustaqeem; Kumar, Vivek; Giri, Pavan Prakash (May 2022). "Synthetic Approach to Potential Anticancer Benzimidazole Derivatives: A Review". Mini-Reviews in Medicinal Chemistry. 22 (9): 1289–1304. doi:10.2174/1389557521666211001122118. ISSN 1389-5575. PMID 34598663.
  5. ↑ "Human Verification". www.eurekaselect.com. doi:10.2174/13895575113139990072. Retrieved 2025-12-04.